Sung HY et al. have demonstrated that SYT2 is up-regulated in ovarian cancer and promotes the migration and invasiveness of ovarian carcinoma cells, and is associated with poor survival for patients with ovarian cancer [13]. Here, SYT2 is linked to ovarian carcinoma.